Efficacy of Oral Appliance for Upper Airway Resistance Syndrome
Primary Purpose
Upper Airway Resistance Syndrome
Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Brazilian Dental Appliance
Placebo
Sponsored by

About this trial
This is an interventional treatment trial for Upper Airway Resistance Syndrome focused on measuring Fatigue, excessive daytime sleepiness, flow limitation
Eligibility Criteria
Inclusion Criteria:
- Both genders
- Body mass index (BMI) ≤ 30Kg/m2
- Age from 25 to 50 years
- Clinical and polysomnographic diagnosis of Upper Airway Resistance Syndrome: Apnea/Hypopnea Index (AIH) ≤ 5 events/hour and Respiratory Disturbance Index (RDI) > 5 events/hour or > 30% of total sleep time with inspiratory flow limitation with excessive daytime somnolence or fatigue
Exclusion Criteria:
- Unsatisfactory dental condition or severe temporomandibular disfunction;
- Nasal obstruction;
- Alcohol abuse and excessive consumption of psychotropic drugs;
- Clinical, neurological or psychiatric diseases not treated
- Less than 6 hours of sleep
Sites / Locations
- Associação Fundo de Incentivo à Pesquisa (AFIP)Recruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Brazilian Dental Appliance
Placebo
Arm Description
The device increases the volume of the airway by mandibular traction.
Oral device that does not change the volume of the airway
Outcomes
Primary Outcome Measures
Fatigue
Modified fatigue impact scale for Portuguese (MFIS- BR)
Secondary Outcome Measures
Subjective excessive daytime sleepiness
Epworth sleepiness scale
Objective excessive daytime sleepiness
Multiple Sleep Latency Test
Mood - Anxiety
Beck inventories (BAI)
Mood - Depression
Beck inventories (BDI)
Sustained attention
Psychomotor Vigilance Test (PVT)
Cognition - Memory
Digit Symbol Substitution Test (DSST)
Cognition - Learning strategies
Rey Auditory-Verbal Learning Test (RAVLT)
Cognition - Immediate and late memories
Wechsler Memory Scale (WMS)
Cognition - Processing speed ability
Stroop Color Test
Cognition - Visual attention
Trail Making Test - TMT
Quality of sleep
Pittsburgh Sleep Quality Index (PSQI)
Quality of life
Functional Outcomes of Sleep Questionnaire (FOSQ)
Stress
Teste de Lipp
Metabolism
Blood analysis of metabolism
Autonomic nervous system analysis
Heart rate variability
Full Information
NCT ID
NCT02636621
First Posted
December 16, 2015
Last Updated
July 14, 2016
Sponsor
Associação Fundo de Incentivo à Pesquisa
1. Study Identification
Unique Protocol Identification Number
NCT02636621
Brief Title
Efficacy of Oral Appliance for Upper Airway Resistance Syndrome
Official Title
Efficacy of Oral Appliance for Upper Airway Resistance Syndrome: Randomized, Parallel, Placebo, Controlled Study
Study Type
Interventional
2. Study Status
Record Verification Date
July 2016
Overall Recruitment Status
Unknown status
Study Start Date
October 2013 (undefined)
Primary Completion Date
October 2017 (Anticipated)
Study Completion Date
October 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Associação Fundo de Incentivo à Pesquisa
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Introduction: The Upper Airway Resistance Syndrome (UARS) is a sleep disorder characterized by airway resistance to breathing during sleep that leads to arousals and daytime sleepiness. There are few studies about UARS treatment and there is not any gold standard treatment for it yet.
Objective: Primary: To evaluate the efficacy of oral appliance on improving fatigue in patients with UARS. Secondary: Evaluate the effects of treatment with oral appliance (OA) in patients with UARS on sleepiness, mood, cognition, quality of life, metabolism and autonomic nervous system.
Methods: Subjects with UARS (Apnea/Hypopnea Index - AHI - ≤ 5 events per hour of sleep and Respiratory Disturbance Index - RDI - > 5 events per hour or more than 30% of total sleep time with inspiratory flow limitation and with excessive daytime somnolence and/or fatigue) of both genders, with body mass index (BMI) lower than 30Kg/m2 and between 25 to 50 years of age will be included. Subjects will be randomly distributed in OA group and placebo (without treatment). At baseline evaluation, 6 months and 1 year after subjects will be submitted to sleep questionnaires, physical exam, otolaryngological evaluation, baseline polysomnography, Epworth sleepiness scale, Multiple Sleep Latency Test, fatigue scale, neurocognitive testing, autonomic nervous system analysis (heart rate variability) and metabolic evaluation. Mean and standard deviation will be used for descriptive statistical analysis if normal distribution, and median and percentiles (25%, 75%) for variables not normally distributed. To compare treatment groups T test (parametric) and Mann Whitney (non parametric) will be used. For adjusted analysis, linear regression analysis will be used.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Upper Airway Resistance Syndrome
Keywords
Fatigue, excessive daytime sleepiness, flow limitation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Brazilian Dental Appliance
Arm Type
Active Comparator
Arm Description
The device increases the volume of the airway by mandibular traction.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Oral device that does not change the volume of the airway
Intervention Type
Device
Intervention Name(s)
Brazilian Dental Appliance
Other Intervention Name(s)
Mandibular advancement device
Intervention Description
Brazilian Dental Appliance is an oral appliance worn only during sleep that supports the jaw in a forward position to help maintain an open upper airway.
Intervention Type
Other
Intervention Name(s)
Placebo
Other Intervention Name(s)
Protective dental plate
Intervention Description
The placebo consists in a protective dental plate worn only during sleep that do not interfere in the size of the upper airway.
Primary Outcome Measure Information:
Title
Fatigue
Description
Modified fatigue impact scale for Portuguese (MFIS- BR)
Time Frame
From the baseline evaluation to one year after the treatment with oral appliance
Secondary Outcome Measure Information:
Title
Subjective excessive daytime sleepiness
Description
Epworth sleepiness scale
Time Frame
From the baseline evaluation to one year after the treatment with oral appliance
Title
Objective excessive daytime sleepiness
Description
Multiple Sleep Latency Test
Time Frame
From the baseline evaluation to one year after the treatment with oral appliance
Title
Mood - Anxiety
Description
Beck inventories (BAI)
Time Frame
From the baseline evaluation to one year after the treatment with oral appliance
Title
Mood - Depression
Description
Beck inventories (BDI)
Time Frame
From the baseline evaluation to one year after the treatment with oral appliance
Title
Sustained attention
Description
Psychomotor Vigilance Test (PVT)
Time Frame
From the baseline evaluation to one year after the treatment with oral appliance
Title
Cognition - Memory
Description
Digit Symbol Substitution Test (DSST)
Time Frame
From the baseline evaluation to one year after the treatment with oral appliance
Title
Cognition - Learning strategies
Description
Rey Auditory-Verbal Learning Test (RAVLT)
Time Frame
From the baseline evaluation to one year after the treatment with oral appliance
Title
Cognition - Immediate and late memories
Description
Wechsler Memory Scale (WMS)
Time Frame
From the baseline evaluation to one year after the treatment with oral appliance
Title
Cognition - Processing speed ability
Description
Stroop Color Test
Time Frame
From the baseline evaluation to one year after the treatment with oral appliance
Title
Cognition - Visual attention
Description
Trail Making Test - TMT
Time Frame
From the baseline evaluation to one year after the treatment with oral appliance
Title
Quality of sleep
Description
Pittsburgh Sleep Quality Index (PSQI)
Time Frame
From the baseline evaluation to one year after the treatment with oral appliance
Title
Quality of life
Description
Functional Outcomes of Sleep Questionnaire (FOSQ)
Time Frame
From the baseline evaluation to one year after the treatment with oral appliance
Title
Stress
Description
Teste de Lipp
Time Frame
From the baseline evaluation to one year after the treatment with oral appliance
Title
Metabolism
Description
Blood analysis of metabolism
Time Frame
From the baseline evaluation to one year after the treatment with oral appliance
Title
Autonomic nervous system analysis
Description
Heart rate variability
Time Frame
From the baseline evaluation to one year after the treatment with oral appliance
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Both genders
Body mass index (BMI) ≤ 30Kg/m2
Age from 25 to 50 years
Clinical and polysomnographic diagnosis of Upper Airway Resistance Syndrome: Apnea/Hypopnea Index (AIH) ≤ 5 events/hour and Respiratory Disturbance Index (RDI) > 5 events/hour or > 30% of total sleep time with inspiratory flow limitation with excessive daytime somnolence or fatigue
Exclusion Criteria:
Unsatisfactory dental condition or severe temporomandibular disfunction;
Nasal obstruction;
Alcohol abuse and excessive consumption of psychotropic drugs;
Clinical, neurological or psychiatric diseases not treated
Less than 6 hours of sleep
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
LUCIANA GODOY, MD
Phone
551121490155
Email
lu_bmg@yahoo.com.br
Facility Information:
Facility Name
Associação Fundo de Incentivo à Pesquisa (AFIP)
City
São Paulo
ZIP/Postal Code
04024-002
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sonia Togeiro, MD, PhD
Email
sonia.togeiro@sono.org.br
First Name & Middle Initial & Last Name & Degree
Luciana Godoy
Email
lu_bmg@yahoo.com.br
First Name & Middle Initial & Last Name & Degree
Sonia G. Togeiro, MD, PhD
First Name & Middle Initial & Last Name & Degree
Cibele Dal-Fabbro, PhD
First Name & Middle Initial & Last Name & Degree
Luciana Palombini, PhD
First Name & Middle Initial & Last Name & Degree
Luciana Godoy, MD
12. IPD Sharing Statement
Citations:
PubMed Identifier
32686643
Citation
de Godoy LBM, Sousa KMM, Palombini LO, Poyares D, Dal-Fabbro C, Guimaraes TM, Tufik S, Togeiro SM. Long term oral appliance therapy decreases stress symptoms in patients with upper airway resistance syndrome. J Clin Sleep Med. 2020 Nov 15;16(11):1857-1862. doi: 10.5664/jcsm.8698.
Results Reference
derived
PubMed Identifier
29045745
Citation
Godoy LBM, Palombini L, Poyares D, Dal-Fabbro C, Guimaraes TM, Klichouvicz PC, Tufik S, Togeiro SM. Long-Term Oral Appliance Therapy Improves Daytime Function and Mood in Upper Airway Resistance Syndrome Patients. Sleep. 2017 Dec 1;40(12). doi: 10.1093/sleep/zsx175.
Results Reference
derived
Learn more about this trial
Efficacy of Oral Appliance for Upper Airway Resistance Syndrome
We'll reach out to this number within 24 hrs